Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Sonye K. Danoff et al.|The Lancet Respiratory Medicine|2022Cited by 211
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitisKarthik Suresh, Franco R. D’Alessio, Jennifer S. Mammen et al.|Journal of Clinical Investigation|2019Cited by 198